| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |